This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Creative BioMart
product type :
antibody
product name :
Anti-CCL2 monoclonal antibody, clone 3I6 [PE]
catalog :
DCABH-10339
quantity :
100 μg
clonality :
monoclonal
host :
hamsters
conjugate :
PE
clone name :
3I6
reactivity :
mouse
application :
flow cytometry
product information
Cat :
DCABH-10339
Product Name :
Anti-CCL2 monoclonal antibody, clone 3I6 [PE]
Brand :
Creative Diagnostics
Abbr :
Anti-CCL2 MAb, PE-Conjugated
Host animal :
Armenian Hamster
Clone :
3I6
Official Symbol :
CCL2
Clonality :
Monoclonal
Application :
FC
Target :
CCL2
Species Reactivity :
Mouse
Conjugate :
PE
Antibody Type :
Primary Antibodies
Immunogen :
Recombinant Mouse MCP1 expressed in CHO cells
Alternative Names :
CCL2; chemokine (C-C motif) ligand 2; C-C motif chemokine 2; small inducible cytokine A2; small-inducible cytokine A2; monocyte chemotactic protein 1; monocyte chemoattractant protein 1; monocyte chemoattractant protein-1; platelet-derived growth factor-i
UniProt ID :
P10148
Antibody Isotype :
IgG
Size :
100 μg
Storage :
Store at +4°C.
company information

Creative BioMart
Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research, molecular diagnostics and biopharmaceutical drug development.
We are offering more than 3,000 recombinant proteins, peptides and antibodies. All the products are rigorously tested to meet the most demanding research needs. At the same time, lowest prices in the industry are always guaranteed.
Also, in order to leverage our core competencies and resources, Creative BioMart has formed a large number of corporate partnerships and academic collaborations for product development and distribution. We welcome potential partners and distributors to explore business relationships with Creative BioMart.
questions and comments